Theratechnologies Inc T.TH

Enterprise Value (EV)

[jeffm34]

On Jan 6/2021 the company's EV was approximately US$228M  

(77M shares x $2.60) + $52M debt - $24M cash 

On Jan 7/2021 the company announced record quarterly sales, approval for a Phase 3 NASH trial and the start of a very broad oncology clinical program. 

Today the company's EV is approximately US$196M 

(93.7M shares x $2.29) + $52M debt - $70M cash

So after becoming a phase 3 NASH company, recording record sales and starting a promising oncology program, management has somehow managed to decrease EV by 14% 

I don't think any of us can truely appreciate how difficult of a task that was even if you were trying.

[houbahop]

Too funny, jeff! It is difficult to achieve such a poor performance. But like you said, the pump and dump trickery has been exposed. Pumping on January 7th with some great news for existing shareholders and dumping 14m shares 5 days later at a price giving most of the value created by the NASH research to the new shareholders. Once again - it has happen many times in the past